Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production

Metabolism: Clinical and Experimental

Volumn 51, Issue 3, 2002, Pages 380-386

  Isenović, Esma ^a,b   Walsh, Mary F ^a,b   Muniyappa, Ranganath ^a,b   Bard, Mara ^a,b   Diglio, Clement A ^a,b   Sowers, James R ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAVEOLIN 1; INSULIN; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOTYROSINE; PROTEIN ANTIBODY; PROTEIN G; PROTEIN P85; SOMATOMEDIN C; TRITON X 100; WORTMANNIN;

ANIMAL CELL; AORTA; ARTICLE; BLOOD VESSEL TONE; CELL LYSATE; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBUNIT; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASODILATATION; WESTERN BLOTTING;

EID: 0036123435     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.30525     Document Type: Article

References (38)

1. Insulin resistance and cardiovascular disease
2. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes
3. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells
4. A novel phosphoinositide 3-kinase activity in myeloid-derived cells is activated by G-protein subunits
5. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology
6. Gene expression of endothelial type isoform of nitric oxide synthase in various tissues of stroke-prone spontaneously hypertensive rats
7. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae
8. Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands
9. Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles
10. A beta-adrenoreceptor agonist evokes a nitric oxide-cGMP relaxation mechanism modulated by adenylyl cyclase in rat aorta. Halothane does not inhibit this mechanism
11. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation
12. Modification of camp-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle
13. Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats
14. Angiogenesis in rat aorta ring explant cultures
15. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology
16. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton
17. Insulin-like growth factor-1 increases vascular smooth muscle nitric oxide production
18. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide
19. Wortmannin inactivates phosphoinositol 3-kinase by covalent modification of Lys802, a residue involved in the phosphate transfer reaction
20. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY2940020)
21. Localization of protein kinases by anchoring proteins: A theme in signal transduction
22. Activation of posphatidylinositol 3-kinase and phosphatidylinositol 4-kinase during rat parotid acinar cell proliferation
23. Caveolae: Where incoming and outgoing messengers meet
24. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: Role of phosphodiesterase 3
25. 2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle
26. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveoloae in cardiac myocytes
27. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle
28. Endothelial nitric oxide synthase targeting to caveolae
29. G beta gamma stimulates phosphoinositide 3-kinase-gamma by direct interaction with two domains of the catalytic p110 subunit
30. Insulin increases the association of Akt-2 with Glut 4-containing vesicles
31. Hypertension in mice lacking the gene for endothelial oxide synthase
32. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasolidation in patients with hypertension: Correlation with beta-receptor function in vitro
33. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats
34. Changes in responsiveness of the aorta to vasorelaxant agents in genetically diabetic rats: A study in WBN/Kob rats
35. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis
36. β-Adrenoreceptor agonist mediated relaxation of rat isolated resistance arteries: A role for the endothelium and nitric oxide
37. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilatation caused by beta-adrenergic agonists in human forearm
38. Diabetes, hypertension, and cardiovascular disease: An update